LASA SUPERGENERICS
|
The Current P/E Ratio of LASA SUPERGENERICS is -5.79.
Share Price | ₹26.3 | Jan 22,2025 |
Market Cap | ₹131.6 Cr | |
Earnings-TTM | ₹-22.7 Cr | TTM-Standalone Results |
Price/Earnings | -5.79x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LASA SUPERGENERICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹131.6 Cr] as on Jan 22,2025
(/) Earnings [ ₹-22.7 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -5.79x ]
Thus, for LASA SUPERGENERICS , the investors are currently willing to pay -5.79 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LASA SUPERGENERICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LASA SUPERGENERICS over the last five years.
Historical PE (Price/Earnings) ratio chart of LASA SUPERGENERICS
PE Ratio Performance Analysis for LASA SUPERGENERICS
- LASA SUPERGENERICS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.51x.
- LASA SUPERGENERICS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LASA SUPERGENERICS 's p/e ratio peaked in Mar2020 at 31.83x.
- LASA SUPERGENERICS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does LASA SUPERGENERICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LASA SUPERGENERICS | -22.72 | -5.79 | 131.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 38.74 | 431,400.0 |
CIPLA LTD | 4,485.22 | 25.92 | 116,240.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.01 | 108,166.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.91 | 98,495.2 |
DIVIS LABORATORIES LTD | 1,836.00 | 84.22 | 154,622.0 |
MANKIND PHARMA LTD | 2,124.86 | 48.83 | 103,763.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 59.48 | 107,179.0 |
LUPIN LTD | 2,651.94 | 36.79 | 97,570.3 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.22 | 69,185.1 |
ABBOTT INDIA LTD | 1,284.66 | 45.89 | 58,958.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LASA SUPERGENERICS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -5.79x |
Max industry PE | 84.22x |
Median industry PE | 36.79x |
Average industry PE | 36.02x |
You may also like the below Video Courses